Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial-Reference-Cited by-同舟云学术

Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial

Published:2004-10 Issue:10 Volume:35 Page:2418-2424
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Ingall Timothy John¹,O’Fallon William Michael¹,Asplund Kjell¹,Goldfrank Lewis Robert¹,Hertzberg Vicki S.¹,Louis Thomas Arthur¹,Christianson Teresa J. Hengy¹

Affiliation:

1. From the Department of Neurology (T.J.I.), Mayo Clinic Scottsdale, Ariz; the Division of Biostatistics (W.M.O., T.J.H.C.), Mayo Clinic Rochester, Minn; the National Board of Health and Welfare (K.A.), Stockholm, Sweden; the Department of Emergency Medicine (L.R.G.), New York University School of Medicine, New York; the Department of Biostatistics (V.S.H.), Emory University, Atlanta, Ga; and the Department of Biostatistics (T.A.L.), Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference33 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. Food and Drug Administration. Clinical Review for PLA 96–0350. 1996. Available at: http://www.fda.gov/cder/biologics/review/altegen061896r2.pdf. Accessed May 20 2004.

3. Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke

4. Intravenous t-PA for acute ischemic stroke: Therapeutic yield of a stroke code system

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adaptive Randomization Method to Prevent Extreme Instances of Group Size and Covariate Imbalance in Stroke Trials;Stroke;2024-08

2. The association of gender with functional outcome in thrombolysed stroke: A secondary analysis of INTRECIS study;Heliyon;2024-06

3. The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17;BMC Medical Research Methodology;2023-11-21

4. High neutrophil-to-lymphocyte ratio (NLR) predicts poor response to intravenous thrombolysis in white Caucasian stroke patients;Journal of Stroke and Cerebrovascular Diseases;2023-11

5. Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR‐TEST and NOR‐TEST 2A;Journal of the American Heart Association;2023-10-17